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Placebo Effects of Caffeine on Short-Term 
Resistance Exercise to Failure
Michael J. Duncan, Mark Lyons, and Joanne Hankey
Purpose: This study examined the placebo effect of caffeine on number of repetitions 
(reps), rating of perceived exertion (RPE), blood pressure (BP), and peak heart rate 
(PHR) during resistance-training exercise with repetitions (reps) performed to voli-
tional failure. Methods: Following determination of 1-rep maximum in single-leg leg 
extension, 15 males performed reps to failure at 60% 1-RM in 3 conditions: control, 
perceived caffeine condition, and perceived placebo condition presented in a random-
ized order. Participants were informed they would ingest 250 mL of solution that 
contained either 3 mg·kg−1 caffeine or 3 mg·kg−1 placebo 1 h before each exercise 
trial. A deceptive protocol was employed and subjects consumed a placebo solution 
in both conditions. During each condition, total reps, RPE for the active muscle and 
overall body, and PHR were recorded. Results: Subjects completed 2 more reps when 
they perceived they had ingested caffeine. RPE was significantly (P = .04) lower in 
the perceived caffeine and control conditions and RPE for the active muscle was sig-
nificantly higher across all conditions compared with RPE for the overall body. No 
substantial differences were evident in PHR across conditions. Conclusions: Results 
of this study are similar to studies of actual caffeine ingestion. However, the percep-
tion of consuming a substance that purportedly enhances performance is sufficient 
enough to enable individuals to complete a greater number of reps to failure during 
short-term resistance exercise.
Keywords: strength, ergogenic, RPE, leg extension, expectancy effect
The placebo effect is a favorable outcome arising purely from the belief that 
one has received a beneficial treatment.1 A wide range of studies have documented 
placebo effects in various domains including psychology and medicine. Although 
the placebo effect influences physiological and psychological variables,2 only 
recently has it been examined systematically in sport and exercise, with findings 
suggesting it is associated with improved performance.1,3,4 Clark et al1 reported a 
3.8% increase in mean power in a 4-km time trial when cyclists were told they had 
received a carbohydrate solution. Likewise, Beedie et al3 reported that cyclists, 
completing a 10-km time trial, produced 1.4% less power, and 1.3% and 3.1% 
greater power when they believed they had ingested 0 mg·kg−1, 4.5 mg·kg−1, and 
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9 mg·kg−1 caffeine respectively. They concluded that participants consuming a 
substance thought to be caffeine produce greater power than at baseline. Semi-
structured interviews revealed that the cyclists perceived caffeine symptoms and 
direct effects on performance as a result of consuming what they thought was caf-
feine. More recently, an electronic survey4 of 48 competitive athletes revealed that 
the majority of respondents (97%) believed that the placebo effect exerted an 
influence on performance and 73% had experienced a placebo effect that posi-
tively influenced their performance. In addition, Foad et al5 found that power 
output during a 40-km cycling time trial improved by 3.5% over baseline when 
participants had consumed caffeine, whether they knew they were receiving caf-
feine or not. However, the belief that caffeine had been ingested resulted in a 2.6% 
increase in performance in the absence of caffeine.
The placebo effect is a potentially important issue relevant to performance as 
nutritional supplementation is widely used in recreational and competitive sports 
settings. In the case of caffeine ingestion, multiple studies have demonstrated 
enhanced performance in aerobic activities6–10 and reduced ratings of perceived 
exertion (RPE) during exercise.11 More recently, studies on caffeine consumption 
have focused on its impact on short-term exercise or resistance exercise. Astorino 
et al12 reported an 11% and 12% increase in total weight lifted at 60% of 1 repeti-
tion maximum (1RM) to failure during the bench press and leg press after caffeine 
consumption compared with placebo. Similarly, Beck et al13 reported greater 1RM 
values for bench press after caffeine consumption. Green et al14 reported that caf-
feine consumption resulted in a greater number of repetitions and higher PHR 
during the third set of leg press to failure at 10RM: these authors concluded that 
caffeine has an ergogenic effect during short-term anaerobic performance without 
alterations in feelings of acute fatigue (RPE).
Some research on ergogenic effects of caffeine on short-term resistance per-
formance has limitations. Notably, in previous studies,12,14,15 participants have 
completed both a placebo and caffeine consumption condition, in which the pla-
cebo serves as a control to examine the impact of caffeine on performance. This is 
problematic if, as research suggests, simply administering a placebo can enhance 
exercise performance,3 the improvement due to caffeine may be masked if com-
paring to a placebo instead of a control condition. Even though these studies (and 
many others) used a double-blind design, the fact that participants and investiga-
tors are unaware which substance they are consuming does not alter the assump-
tion that the placebo condition is inactive (ie, that it will not have an effect) or that 
an active substance may act differently when participants believe they have 
ingested it than when they believe they have not.5,16 Even in a double-blind 
research design, the process of consuming a substance may lead to some form of 
expectancy or active searching for performance-enhancing symptoms. The fact 
that these studies12,14,15 did not include a control condition (ie, without consump-
tion of any substance) does not account for these assumptions.
Research on short-term resistance exercise has not considered whether it is 
the expectancy of the effect of caffeine that causes an improvement in perfor-
mance rather than the caffeine itself. No previous studies have examined the pla-
cebo effect of caffeine during short-term, high-intensity resistance exercise. The 
aim of this study was to examine placebo effects of caffeine on short-term resis-
tance exercise.
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Method
Subjects
Following institutional ethics approval and informed consent, 12 males (mean age 
± SD = 22.7 ± 6.0 years) volunteered to participate. All participants had experi-
ence performing resistance exercise and were free of musculoskeletal pain or dis-
orders. All participants were asked to refrain from vigorous exercise and maintain 
normal dietary patterns in the 24 h before testing and not to consume caffeine after 
6:00 PM the night before testing to control for the effects of caffeine already 
consumed.17
Design
This study employed a within-subjects repeated measures design. Participants 
were informed they were participating in a study examining the impact of caffeine 
ingestion on resistance exercise performance. Subjects were told they would con-
sume two solutions, presented in a random order, one containing 3 mg·kg−1 caf-
feine and one containing a placebo. In accordance with protocols used previously, 
before the performance trials, and with the aim of catalyzing or reinforcing beliefs 
about caffeine, participants were provided with literature reviewing the findings 
of published research into caffeine and resistance exercise.3
Procedure
Each participant attended the human performance laboratory on three occasions. 
All testing took place between 9:00 AM and 12:00 PM and at the same time for 
each participant to avoid circadian variation. The first visit to the laboratory 
involved a briefing session and determination of each participant’s 1-repetition 
maximum (1RM) on the single leg extension. All participants had experience per-
forming resistance exercises in general and leg extension exercise in particular. 
Before commencing the 1RM, the unilateral leg extension was demonstrated to 
each participant. Each participant also performed 8 to 10 unweighted unilateral 
leg extensions before the experimental protocol. The 1RM was determined accord-
ing to methods advocated by Kraemer, Ratamess, Fry, and French.18 The 1RM 
value was used to set the 60% 1RM intensity undertaken during the proceeding 
experimental trials.
During each condition participants undertook a 5-min submaximal warm-up 
on a cycle ergometer and completed one set of single-leg leg extension exercise to 
failure at 60% 1RM. Conditions were presented in a randomized order and were 
separated by 24 to 72 h. One condition was used as a control trial and involved no 
consumption of any substance. In the other two conditions, participants were 
informed they would consume either 3 mg·kg−1 caffeine or a placebo diluted into 
solution on a randomly assigned basis. However, a deceptive administration 
protocol1,5,16,17 was employed whereby participants only consumed 250 mL of 
artificially sweetened water drink 60 min before each exercise trial. In the case of 
the current study, neither the participants nor the researchers administering the 
solutions were made aware of the true nature of the research (or content of the 
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solutions) until the study had ended. Each solution was presented to participants 
in an opaque sports bottle to prevent the researchers and participants from actually 
seeing the solutions themselves.
Lifting Procedures
Leg extension exercise was performed for the dominant leg using a Nova leg 
extension machine (Nova Inc, United Kingdom) in accordance with protocols 
described by Earle and Baechle.19 A trained researcher was present during all test-
ing sessions to ensure proper range of motion. Any lift that deviated from proper 
technique was not counted. During all conditions, repetition frequency was paced 
by a metronome set at 60 bpm. This cadence resulted in one complete repetition 
every 4 s with concentric and eccentric phases comprising 2 s each. The actual 
mass lifted during each condition was screened from participants during all trials 
using a purpose-built board slotted in front of the weight stack. Feedback related 
to lifting procedures or the number of repetitions completed was not made avail-
able to participants until completion of all procedures.
Performance Measures
During each condition, repetitions were counted using a hand tally counter 
(Tamaco Ltd, Japan) and peak heart rate assessed using heart rate telemetry (Polar 
Electro Oy, Kempele, Finland). Studies of PHR report no substantial differences 
between upper and body resistance exercise matched for intensity24 and used PHR 
as a measure of physiological strain during leg extension exercise to failure 
specifically.20,21 Systolic and diastolic blood pressure were assessed immediately 
after exercise using automated sphygmomanometry (Omron 509, Omron Health-
care, Inc, Illinois, USA). Total weight lifted was calculated by multiplying the 
mass lifted by the number of repetitions completed. Immediately after each par-
ticipant had reached failure, they were asked to provide an undifferentiated (RPE 
for the overall body, RPE-O) and a differentiated (RPE for active muscle, 
RPE-AM) rating of perceived exertion using the Borg 6 to 20 RPE scale.22
Once the experimental protocol had been completed, but before participants 
were informed of the values assessed during each condition, participants were 
asked to indicate which trial they perceived to be the caffeine ingestion trial and 
to provide an explanation for their decision. The participants were asked, “Please 
identify which trial was the trial where caffeine was consumed and which was the 
trial where the placebo was consumed.” Participants were then asked, “Please 
could you explain why you believe this to be the case” and “Are there any other 
reasons why you think this was the case.” The response to the first question was 
also used to allocate trial to condition. Following completion of all conditions and 
each participant’s explanations, participants were thoroughly debriefed as to the 
true nature of the study.
Data Analysis
Changes in total repetitions completed, total weight lifted, systolic and diastolic 
blood pressure, and peak heart rate were analyzed using one-way repeated mea-
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sures ANOVA. Changes in RPE were analyzed using a 3 (Condition)  2 (RPE 
Region) repeated measures ANOVA. Post hoc analysis using Bonferroni adjust-
ment was performed where any significant interactions and main effects were 
found. Partial 2 was also calculated as a measure of effect size. A P value of 0.05 
was used to establish statistical significance and the Statistical Package for Social 
Sciences (SPSS, Inc, Chicago, Ill) Version 15.0 was used for all analyses.
Results
There were significant differences in the total repetitions completed (F2, 28 = 22.33, 
P = .001, partial 2 = .615) and total weight lifted (F2, 28 = 18.11, P = .01, partial 
2 = .564) across conditions. Participants completed significantly more repetitions 
(mean difference = 4.1) and lifted more weight (mean difference = 139.1) when 
they believed they had consumed caffeine compared with the control condition 
and when they thought they had consumed placebo (mean difference = 72.1). 
However, there was no significant difference in systolic blood pressure, diastolic 
blood pressure, or peak heart rate across conditions. Repetitions, total weight 
lifted, diastolic and systolic blood pressure, and peak heart rate across conditions 
are shown in Table 1.
In relation to RPE, results indicated that RPE was significantly higher during 
the trial where participants believed they had consumed placebo compared with 
when participants perceived that they had consumed caffeine and during the con-
trol condition (F2,28 = 6.61, P = .04, partial 2= .321). Mean ± SD for RPE was 
13.8 ± 1.9, 14.2 ± 1.6 and 14.9 ± 1.6 for the control, perceived caffeine, and per-
ceived placebo conditions respectively. RPE for the active muscle was also sig-
nificantly higher than RPE for the overall body across trials (F1,14 = 54.8, P = .001, 
partial 2 = .797). Mean ± SD of RPE was 16.2 ± 1.7 and 12.4 ± 1.6 for the active 
muscle and overall body respectively. A significant Condition  Region RPE 
interaction (F2,28 = 4.96, P = .01, partial 2 = .262) indicated that RPE for the 
overall body was similar across all conditions, but that RPE for the active muscles 
was elevated during the perceived placebo condition compared with the control 
and perceived caffeine conditions (see Figure 1).
Thirteen of the fifteen participants indicated that they expected caffeine to 
have a positive effect on their performance. Five of the participants reported direct 
effects of caffeine on performance (three of these participants also reported per-
formance-related effects).
Discussion
When individuals consumed a substance that they believed to be caffeine they 
completed more repetitions to failure and lifted more weight than when they had 
consumed a substance they believed to be placebo. These results support the find-
ings of studies that have examined the placebo effect during aerobically based 
exercise tasks1,3 and are consistent with studies that have examined the impact of 
caffeine consumption on resistance exercise.12,14 The RPE results are consistent 
with other studies that also reported dampened RPE during exercise when caf-
feine was consumed compared with placebo.11 In the current study, this dampen-
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ing appears to specifically act on feelings of exertion in the active musculature. 
However, in both the main effect for RPE and the significant Condition  RPE 
region interaction, RPE values were significantly greater in the perceived placebo 
condition in comparison with the control and perceived caffeine conditions. How-
ever, the absence of significant differences between control and perceived caffeine 
conditions implies that the belief that an ergogenic substance has been adminis-
tered was not sufficient to influence perception of exertion. In this respect, a nega-
tive (or nocebo) effect may have occurred. Negative beliefs about consumption of 
a substance may elicit a negative, or nocebo, effect where performance is poorer 
than baseline performance.23 In this case, it may be that the placebo effect mani-
fests itself in increased effort. Further, larger scale study of this issue is needed to 
clarify this finding.
Eighty-three percent of the participants in the current study expected caffeine 
to have an effect on performance. This observation is important as the exact mech-
anisms by which caffeine exerts its ergogenic effects are still unresolved.13 
Although several physiological mechanisms have been proposed,9,24 it appears 
that simply informing an individual that they will be given a performance-enhanc-
ing substance can improve performance. This finding is consistent with other 
studies of the placebo effect.2,6
It is not known whether the placebo effect is manifest as a direct effect on 
performance, or whether the participant becomes more aware in searching for 
caffeine-related symptoms, which leads to changes in performance strategy. As 
there was no significant difference in peak heart rate across conditions in the cur-
rent study, we consider that the level of physiological strain was similar. Despite 
this, it is possible that performance on the task used in the current study may be 
Figure 1 — RPE for the active muscle (RPE-A) and overall body (RPE-O) across condi-
tions (Mean ± SD).
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limited by local muscle endurance rather than cardiovascular factors. Another 
possibility is that the unilateral leg extensions were not sufficient to elicit large 
changes in heart rate. Future research on this topic might use others means to 
monitor physiological load or strain when using leg extension exercise to failure.
All participants in the current study reported either caffeine-related symp-
toms or performance effects of caffeine. Some participants reported both, while 
others reported only caffeine-related symptoms. It is logical to assume that some 
participants monitored their own performance as a means to obtaining some feed-
back on their performance. The researchers sought to minimize this possibility by 
shielding the mass that each participant lifted: there was no pattern in the trials 
that were identified as the “perceived caffeine” and “perceived placebo” trials. 
Eight of the participants identified their second trial in which they had consumed 
a solution as the trial where caffeine had been consumed, with seven participants 
identifying the first trial as this condition. However, this shortcoming should be 
considered as a limitation of the current study and future research should control 
for performance feedback more effectively. The lack of controls for learning 
effects should also be taken into account in future work. Although the postexperi-
mental questioning was brief it appears that a form of belief was involved. Con-
gruent with other studies of the placebo effect,1,3 it is possible that these beliefs 
result in modification of psychological processes such as expectancy, belief, or 
arousal. Future research should benefit from using a more in-depth postexperi-
mental interview to fully elucidate these issues.
There are a number of limitations of experimental research that has examined 
the placebo effect. This study, and other placebo effect studies in the sport and 
exercise setting,1,3,5 have typically been laboratory based and whether placebo 
effects are artifacts of the research setting that would be overridden in real-world 
settings is unclear.16 Furthermore, previous experimental studies have tended to 
assume that the placebo effect is static and any placebo effect is positive compared 
with baseline performance.23 A placebo effect might exert a negative influence on 
performance21 as might be the case in respect to RPE values reported in this study. 
Finally, use of a deceptive administration protocol is predicated on the fact that 
participants are told that they will be taking a particular substance and so the 
experimental data are not truly blind. Foad et al5 have used the double disassocia-
tion design to examine placebo effects. This may merit consideration by future 
researchers interested in this topic.
The placebo effect may not be the only explanation for the findings of the 
current study. Low a priori expectations of performance in the perceived placebo 
condition or because of the motivational climate fostered by the situation may be 
a factor. If a performer had low expectations in the condition that they believed 
was the placebo condition, any difference in performance between the perceived 
caffeine and perceived placebo trials may have been magnified. Personality char-
acteristics may predispose an individual to respond to a placebo.25 Future research 
should address issues of personality, motivational climate, and responsiveness 
when examining placebo effects.
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Practical Applications
Considerable attention has been paid to the use of substances purported to enhance 
sports and exercise performance. This work has included pharmacological agents 
such as caffeine. There is a placebo effect of caffeine that can provide a perfor-
mance benefit during an acute bout of short-term resistance exercise to failure. In 
this case it appears that the belief that a substance that might enhance performance 
has been ingested was sufficient to improve performance. Coaches and trainers 
could benefit by utilizing the placebo effect within exercise settings to enhance 
resistance exercise performance.
Conclusions
The perception that consuming a substance will enhance performance is sufficient 
to enable individuals to complete a greater number of repetitions compared with 
control or perceived placebo conditions. The exact mechanism of this placebo 
effect is unknown and further investigation of this issue is warranted. A greater 
range of physiological responses in the placebo effect that examine the time course 
of the placebo effect in exercise settings is indicated.
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